首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Immunoadsorption method using immunoglobulin Adsopak in adult cases with ITP resistant to splenectomy and other medical therapies.
【24h】

Immunoadsorption method using immunoglobulin Adsopak in adult cases with ITP resistant to splenectomy and other medical therapies.

机译:在患有脾切除术和其他药物治疗的ITP成人病例中,使用免疫球蛋白Adsopak的免疫吸附方法。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Despite all medical therapies and splenectomy performed, severe life-threatening thrombocytopenia persists in many adult patients. AIM OF THE STUDY: To evaluate the efficiency of Immunoglobulin Adsopak immunoadsorption method in eliminating circulating immunocomplexes and IgG from plasma in these cases. METHODS: The method of POCARD Ig-Adsopak Wide Spectrum was applied to four cases with severe thrombocytopenia (< or =20.000/microL) by treating with a daily plasma of 0.25-2 L for 6 days. Platelet counts were recorded at the beginning and during administration of the method. For long-term effects, the cases were called for monthly controls during which platelet counts were measured. RESULTS: Platelet counts of four cases started to increase on average as of the first day. On Day 11, the platelet count reached 50.000/microL. On the following days (Day 17), platelet count was recorded as 90.000/microL. Cases were followed up for a mean of 2 years. At the end of 2 years, mean platelet count of the patients was 210.000 (175.000-265.000) microL. CONCLUSION: In adult cases who do not respond to surgical and medical therapy, including splenectomy, the results obtained from the therapy using the method of Immunoadsorption with Immunoglobulin Adsopak are promising both in short and long-term follow up.
机译:背景:尽管进行了所有药物治疗和脾切除术,但许多成年患者仍然存在严重的危及生命的血小板减少症。研究目的:在这些情况下,评估免疫球蛋白Adsopak免疫吸附方法从血浆中消除循环免疫复合物和IgG的效率。方法:将POCARD Ig-Adsopak广谱法通过每日血浆0.25-2 L治疗6天,用于4例严重血小板减少症(<或= 20.000 / microL)的患者。在该方法开始时和给药过程中记录血小板计数。为了获得长期效果,要求对这些病例进行每月对照,在此期间测量血小板计数。结果:从第一天开始,四例患者的血小板计数开始平均增加。在第11天,血小板计数达到50.000 / microL。在接下来的几天(第17天),血小板计数记录为90.000 / microL。病例平均随访2年。在2年末,患者的平均血小板计数为210.000(175.000-265.000)microL。结论:在对包括脾切除术在内的外科手术和药物治疗均无反应的成年患者中,采用免疫球蛋白和免疫球蛋白Adsopak的方法从治疗中获得的结果在短期和长期随访中都是有希望的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号